99 related articles for article (PubMed ID: 17548222)
1. Immunologically relevant strain polymorphism in the Amastigote Surface Protein 2 of Trypanosoma cruzi.
Claser C; Espíndola NM; Sasso G; Vaz AJ; Boscardin SB; Rodrigues MM
Microbes Infect; 2007 Jul; 9(8):1011-9. PubMed ID: 17548222
[TBL] [Abstract][Full Text] [Related]
2. Novel protective antigens expressed by Trypanosoma cruzi amastigotes provide immunity to mice highly susceptible to Chagas' disease.
Silveira EL; Claser C; Haolla FA; Zanella LG; Rodrigues MM
Clin Vaccine Immunol; 2008 Aug; 15(8):1292-300. PubMed ID: 18579696
[TBL] [Abstract][Full Text] [Related]
3. Protective immunity against trypanosoma cruzi infection in a highly susceptible mouse strain after vaccination with genes encoding the amastigote surface protein-2 and trans-sialidase.
Vasconcelos JR; Hiyane MI; Marinho CR; Claser C; Machado AM; Gazzinelli RT; Bruña-Romero O; Alvarez JM; Boscardin SB; Rodrigues MM
Hum Gene Ther; 2004 Sep; 15(9):878-86. PubMed ID: 15353042
[TBL] [Abstract][Full Text] [Related]
4. Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection.
Haolla FA; Claser C; de Alencar BC; Tzelepis F; de Vasconcelos JR; de Oliveira G; Silvério JC; Machado AV; Lannes-Vieira J; Bruna-Romero O; Gazzinelli RT; dos Santos RR; Soares MB; Rodrigues MM
Vaccine; 2009 Sep; 27(41):5644-53. PubMed ID: 19635607
[TBL] [Abstract][Full Text] [Related]
5. Trypanosoma cruzi: amastigote polymorphism defined by monoclonal antibodies.
Verbisck NV; Da-Silva S; Mortara RA
Braz J Med Biol Res; 1998 Dec; 31(12):1583-91. PubMed ID: 9951555
[TBL] [Abstract][Full Text] [Related]
6. CD8+-T-cell-dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2.
Araújo AF; de Alencar BC; Vasconcelos JR; Hiyane MI; Marinho CR; Penido ML; Boscardin SB; Hoft DF; Gazzinelli RT; Rodrigues MM
Infect Immun; 2005 Sep; 73(9):6017-25. PubMed ID: 16113322
[TBL] [Abstract][Full Text] [Related]
7. Immunization with cDNA expressed by amastigotes of Trypanosoma cruzi elicits protective immune response against experimental infection.
Boscardin SB; Kinoshita SS; Fujimura AE; Rodrigues MM
Infect Immun; 2003 May; 71(5):2744-57. PubMed ID: 12704149
[TBL] [Abstract][Full Text] [Related]
8. Genetic immunization based on the ubiquitin-fusion degradation pathway against Trypanosoma cruzi.
Chou B; Hiromatsu K; Hisaeda H; Duan X; Imai T; Murata S; Tanaka K; Himeno K
Biochem Biophys Res Commun; 2010 Feb; 392(3):277-82. PubMed ID: 20059980
[TBL] [Abstract][Full Text] [Related]
9. The identification and molecular characterization of Trypanosoma cruzi amastigote surface protein-1, a member of the trans-sialidase gene super-family.
Santos MA; Garg N; Tarleton RL
Mol Biochem Parasitol; 1997 May; 86(1):1-11. PubMed ID: 9178263
[TBL] [Abstract][Full Text] [Related]
10. Biological and immunological characterization of recombinant Yellow Fever 17D viruses expressing a Trypanosoma cruzi Amastigote Surface Protein-2 CD8+ T cell epitope at two distinct regions of the genome.
Nogueira RT; Nogueira AR; Pereira MC; Rodrigues MM; Galler R; Bonaldo MC
Virol J; 2011 Mar; 8():127. PubMed ID: 21418577
[TBL] [Abstract][Full Text] [Related]
11. Amastigote surface proteins of Trypanosoma cruzi are targets for CD8+ CTL.
Low HP; Santos MA; Wizel B; Tarleton RL
J Immunol; 1998 Feb; 160(4):1817-23. PubMed ID: 9469442
[TBL] [Abstract][Full Text] [Related]
12. Identification of strain-specific B-cell epitopes in Trypanosoma cruzi using genome-scale epitope prediction and high-throughput immunoscreening with peptide arrays.
Mendes TA; Reis Cunha JL; de Almeida Lourdes R; Rodrigues Luiz GF; Lemos LD; dos Santos AR; da Câmara AC; Galvão LM; Bern C; Gilman RH; Fujiwara RT; Gazzinelli RT; Bartholomeu DC
PLoS Negl Trop Dis; 2013; 7(10):e2524. PubMed ID: 24205430
[TBL] [Abstract][Full Text] [Related]
13. An immunoinformatic approach for identification of Trypanosoma cruzi HLA-A2-restricted CD8(+) T cell epitopes.
Eickhoff CS; Van Aartsen D; Terry FE; Meymandi SK; Traina MM; Hernandez S; Martin WD; Moise L; De Groot AS; Hoft DF
Hum Vaccin Immunother; 2015; 11(9):2322-8. PubMed ID: 26107442
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of Trypanosoma cruzi, T. cruzi marinkellei, T. dionisii and T. vespertilionis by monoclonal antibodies.
Petry K; Baltz T; Schottelius J
Acta Trop; 1986 Mar; 43(1):5-13. PubMed ID: 2424290
[TBL] [Abstract][Full Text] [Related]
15. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2.
Duan X; Yonemitsu Y; Chou B; Yoshida K; Tanaka S; Hasegawa M; Tetsutani K; Ishida H; Himeno K; Hisaeda H
Vaccine; 2009 Oct; 27(44):6154-9. PubMed ID: 19712768
[TBL] [Abstract][Full Text] [Related]
16. cDNA cloning and partial characterization of amastigote specific surface protein from Trypanosoma cruzi.
Olivas-Rubio M; Hernández-Martínez S; Talamás-Rohana P; Tsutsumi V; Reyes-López PA; Rosales-Encina JL
Infect Genet Evol; 2009 Dec; 9(6):1083-91. PubMed ID: 19481174
[TBL] [Abstract][Full Text] [Related]
17. Expression, purification, immunogenicity, and protective efficacy of a recombinant Tc24 antigen as a vaccine against Trypanosoma cruzi infection in mice.
Martinez-Campos V; Martinez-Vega P; Ramirez-Sierra MJ; Rosado-Vallado M; Seid CA; Hudspeth EM; Wei J; Liu Z; Kwityn C; Hammond M; Ortega-López J; Zhan B; Hotez PJ; Bottazzi ME; Dumonteil E
Vaccine; 2015 Aug; 33(36):4505-12. PubMed ID: 26192358
[TBL] [Abstract][Full Text] [Related]
18. Genetic vaccination against experimental infection with myotropic parasite strains of Trypanosoma cruzi.
Araújo AF; de Oliveira G; Vasconcelos JF; Ersching J; Dominguez MR; Vasconcelos JR; Machado AV; Gazzinelli RT; Bruna-Romero O; Soares MB; Rodrigues MM
Mediators Inflamm; 2014; 2014():605023. PubMed ID: 25061263
[TBL] [Abstract][Full Text] [Related]
19. Comparative transcriptome profiling of virulent and non-virulent Trypanosoma cruzi underlines the role of surface proteins during infection.
Belew AT; Junqueira C; Rodrigues-Luiz GF; Valente BM; Oliveira AER; Polidoro RB; Zuccherato LW; Bartholomeu DC; Schenkman S; Gazzinelli RT; Burleigh BA; El-Sayed NM; Teixeira SMR
PLoS Pathog; 2017 Dec; 13(12):e1006767. PubMed ID: 29240831
[TBL] [Abstract][Full Text] [Related]
20. Identification of Trypanosoma cruzi trans-sialidase family members as targets of protective CD8+ TC1 responses.
Wizel B; Nunes M; Tarleton RL
J Immunol; 1997 Dec; 159(12):6120-30. PubMed ID: 9550413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
